Stock 300009 ANHUI ANKE BIOTECHNOLOGY (GROUP) CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Anhui Anke Biotechnology (Group) Co., Ltd.

Equities

300009

CNE100000GY2

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
9.85 CNY +3.14% Intraday chart for Anhui Anke Biotechnology (Group) Co., Ltd. +0.10% -3.62%
Apr. 25 Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 27 Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Anhui Anke Biotechnology (Group) Co., Ltd is a China-based company principally engaged in the research, development, manufacture and distribution of biological products, Chinese patent drugs, chemical synthetic drugs, peptide drugs and nucleic acid detection products. The Company’s main products include recombinant human interferon alfa-2b series, recombinant human growth hormone, peptides Active Pharmaceutical Ingredients (APIs), customized peptides, deoxyribonucleic acid (DNA) fluorescence detection kit, silica beads extraction kit, anti-sperm antibody test kit, pain relieving ointment, amoxicillin granules and capsules, cefaclor dispersible tablets and adefovir dipivoxil tablets, among others. The Company distributes its products in domestic market and to overseas markets.

Number of employees: 2,986

Sales per Business

CNY in Million2022Weight2023Weight Delta
Biological Product
73.3 %
1,556 66.8 % 2,100 73.3 % +34.93%
Chinese Patent Medicine
12.5 %
404 17.4 % 358 12.5 % -11.42%
Chemical Synthetic Medicine
6.2 %
147 6.3 % 179 6.2 % +21.09%
Raw Material
3.2 %
72 3.1 % 92 3.2 % +26.86%
Others
2.8 %
74 3.2 % 79 2.8 % +6.49%
Technical Services
2.0 %
76 3.3 % 58 2.0 % -23.63%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.7 %
2,323 99.6 % 2,858 99.7 % +23.05%
Global
0.2 %
4 0.2 % 5 0.2 % +9.36%
Foreign
0.1 %
4 0.2 % 3 0.1 % -27.28%

Managers

Managers TitleAgeSince
Li Hua Song CEO
 Chief Executive Officer 67 93-04-30
Xian Yu Du CHM
 Chairman 54 -
Jian Ping Yao PSD
 President 52 -
Yuan Yuan Zhou BRD
 Director/Board Member 52 22-06-15
Zeng Li Li BRD
 Director/Board Member 43 -
Jun Pei Jiang BRD
 Director/Board Member 47 -
Yong Bin Wang BRD
 Director/Board Member 56 13-11-04
Kun Li BRD
 Director/Board Member 42 -
Li Ming Song
62 -
Hui Zhao BRD
 Director/Board Member 50 07-04-08

Members of the board

Members of the board TitleAgeSince
Hui Zhao BRD
 Director/Board Member 50 07-04-08
Li Hua Song CEO
 Chief Executive Officer 67 93-04-30
Li Ming Song BRD
 Director/Board Member 62 03-07-31
Xian Yu Du CHM
 Chairman 54 -
Wei Dong Zhu BRD
 Director/Board Member 62 -
Kun Li BRD
 Director/Board Member 42 -
Yong Bin Wang BRD
 Director/Board Member 56 13-11-04
Jun Pei Jiang BRD
 Director/Board Member 47 -
Zeng Li Li BRD
 Director/Board Member 43 -
Yuan Yuan Zhou BRD
 Director/Board Member 52 22-06-15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,719,375,364 1,540,332,671 ( 89.59 %) 42,548,606 ( 2.475 %) 89.59 %

Shareholders

NameEquities%Valuation
Li Hua Song
9.621 %
111,554,678 9.621 % 150 M ¥
Li Ming Song
2.477 %
28,722,355 2.477 % 39 M ¥
Aegon-Industrial Fund Management Co., Ltd.
2.267 %
26,279,440 2.267 % 35 M ¥
China Merchants Fund Management Co., Ltd.
1.811 %
21,002,462 1.811 % 28 M ¥
Ming Fei Li
1.685 %
19,541,373 1.685 % 26 M ¥
Yong Biao Fu
1.382 %
16,026,504 1.382 % 22 M ¥
E Fund Management Co., Ltd.
1.312 %
15,213,002 1.312 % 20 M ¥
Rong Hai Wang
1.209 %
14,013,963 1.209 % 19 M ¥
Jin Xian Du
1.030 %
11,943,000 1.030 % 16 M ¥
China Southern Asset Management Co., Ltd.
1.018 %
11,797,940 1.018 % 16 M ¥
NameEquities%Valuation
Li Hua Song
66.46 %
333,209,032 66.46 % 448 M ¥
Li Ming Song
17.19 %
86,167,065 17.19 % 116 M ¥
Yong Biao Fu
2.572 %
12,892,938 2.572 % 17 M ¥
Rong Hai Wang
2.096 %
10,510,472 2.096 % 14 M ¥
Hui Zhao
1.501 %
7,527,375 1.501 % 10 M ¥
Jian Ping Yao
0.9625 %
4,825,676 0.9625 % 6 M ¥
Hai Sheng
0.5375 %
2,694,829 0.5375 % 4 M ¥
Yuan Yuan Zhou
0.2903 %
1,455,422 0.2903 % 2 M ¥
Jun Pei Jiang
0.1461 %
732,561 0.1461 % 985 199 ¥
Hong Yi Yao
0.1201 %
602,201 0.1201 % 809 882 ¥

Holdings

NameEquities%Valuation
ANHUI ANKE BIOTECHNOLOGY (GROUP) CO., LTD.
0.36%
 4,187,406 0.36% 5,631,517 $

Company contact information

Anhui Anke Biotechnology (Group) Co., Ltd.

K-1, Guanhai Road 669 Changjiang West Road

230088, Hefei

+

http://www.ankebio.com
address Anhui Anke Biotechnology (Group) Co., Ltd.(300009)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Anhui Anke Biotechnology (Group) Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
9.85 CNY
Average target price
19.54 CNY
Spread / Average Target
+98.38%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
ANHUI ANKE BIOTECHNOLOGY (GROUP) CO., LTD. Stock Anhui Anke Biotechnology (Group) Co., Ltd.
-3.62% 2.2B
CSL LIMITED Stock CSL Limited
-4.67% 87.31B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+2.63% 40.86B
BIOGEN INC. Stock Biogen Inc.
-21.76% 29.36B
UCB Stock UCB
+58.56% 24.49B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-14.78% 17.31B
INCYTE CORPORATION Stock Incyte Corporation
-18.49% 11.62B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-15.61% 11.31B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-44.02% 11.26B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.17% 8.31B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 300009 Stock
  4. Company Anhui Anke Biotechnology (Group) Co., Ltd.